Nephron Pharmaceuticals Corp Visit Nephron Pharm on Twitter Visit Nephron Pharm on Facebook Visit Nephron Pharm on Linked In
Nephron Pharm
Nephron Pharm
Nephron Pharm
Nephron Pharm
Nephron Pharm
Nephron Pharm
Nephron Pharm
Today is: March 27, 2017

Budesonide Inhalation Suspension

 

Description:

Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age.

Budesonide Inhalation Suspension is available as:

Budesonide Inhalation Suspension 0.5 mg / 2mL

  • 0487-9701-01 (30 individually wrapped and barcoded vials)
  • 0487-9701-30 (30 bulk wrapped vials)

and

Budesonide Inhalation Suspension 0.25 mg / 2mL

  • 0487-9601-01 (30 individually wrapped and barcoded vials)
  • 0487-9601-30 (30 bulk wrapped vials)

Each unit dose is:

  • Sterile unit dose
  • Bar coded
  • Foil pouched and embossed vials for easy identification

For prescribing information on this product, please download the documents below:

GetAdobeReader

Budesonide Inhalation Suspension

Budesonide Inhalation Suspension

Budesonide Inhalation Suspension

« BACK
Nephron Pharm
Nephron Pharm
Nephron Pharm
Nephron Pharm
Nephron Pharm
Nephron Pharm Nephron Pharm Nephron Pharm
Nephron Pharm
Verified-Accredited Wholesale Distributors® (VAWD®)
Nephron Pharm
Nephron Pharm
Nephron Pharm
Nephron Pharm
Nephron Pharm  
Nephron Pharm